MiR-200c inhibits metastasis of breast cancer cells by targeting HMGB1

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 34, Issue 2, 2014, Pages 201-206

  Chang, Bao Ping ^a,b   Wang, Dong Sheng ^b   Xing, Jian Wu ^b   Yang, Shao Hua ^c   Chu, Qian ^a   Yu, Shi Ying ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c KingMed Diagnostics   (China)

Author keywords

breast cancer; HMGB1; metastasis; miR 200c

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; HOMEODOMAIN PROTEIN; MICRORNA; MIRN200 MICRORNA, HUMAN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TUMOR MARKER; ZEB1 PROTEIN, HUMAN; ZEB2 PROTEIN, HUMAN;

ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; METASTASIS; PATHOLOGY; TUMOR INVASION;

BREAST NEOPLASMS; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HMGB1 PROTEIN; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84898917334     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-014-1259-3     Document Type: Article

References (30)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin, 2013,63(1):11-30
2. Jiang P, Enomoto A, Takahashi M. Cell biology of the movement of breast cancer cells: intracellular signaling and the actin cytoskeleton. Cancer Lett, 2009,284(2):122-130
3. Graves P, Zeng Y. Biogenesis of mammalian microRNAs: a global view. Genomics Proteomics Bioinformatics, 2012,10(5):239-245
4. Macfarlane LA, Murphy PR. MicroRNA: biogenesis, function and role in cancer. Curr Genomics, 2010,11(7):537-561
5. Burk U, Schubert J, Wellner U, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep, 2008,9(6):582-589
6. Peter ME. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle, 2009,8(6):843-852
7. Shimono Y, Zabala M, Cho RW, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell, 2009,138(3):592-603
8. Schickel R, Park SM, Murmann AE, et al. mir-200c regulates induction of apoptosis through CD95 by targeting FAP-1. Mol Cell, 2010,38(6):908-915
9. Chang CJ, Chao CH, Xia W, et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol, 2011,13(3):317-323
10. Cochrane DR, Spoelstra NS, Howe EN, et al. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol Cancer Ther, 2009,8(5):1055-1066
11. Lin J, Liu C, Gao F, et al. miR-200c enhances radiosensitivity of human breast cancer cells. J Cell Biochem, 2013,114(3):606-615
12. Ahmad A, Aboukameel A, Kong D, et al. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells. Cancer Res, 2011,71(9):3400-3409
13. Howe EN, Cochrane DR, Cittelly DM, et al. miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer. PLoS One, 2012,7(11):e49987
14. Jurmeister S, Baumann M, Balwierz A, et al. MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F. Mol Cell Biol, 2012,32(3):633-651
15. Chen Y, Sun Y, Chen L, et al. miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling. Mol Med Rep, 2013,7(5):1579-1584
16. Nikoletopoulou V, Markaki M, Palikaras K, et al. Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta, 2013,1833(12):3448-3459
17. Ko YB, Kim BR, Nam SL, et al. High-mobility group box 1 (HMGB1) protein regulates tumor-associated cell migration through the interaction with BTB domain. Cell Signal, 2014,26(4):777-783
18. Tang D, Kang R, Zeh HJ 3rd, et al. High-mobility group box 1 and cancer. BBA, 2010,1799(1-2):131-140
19. Sparatore B, Patrone M, Passalacqua M, et al. Activation of A431 human carcinoma cell motility by extracellular high-mobility group box 1 protein and epidermal growth factor stimuli. Biochem J, 2005,389(1):215-221
20. Brezniceanu ML, Völp K, Bösser S, et al. HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB J, 2003,17(10):1295-1297
21. Livesey KM, Kang R, Vernon P, et al. p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res, 2012,72(8):1996-2005
22. van Beijnum JR, Nowak-Sliwinska P, van den Boezem E, et al. Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1. Oncogene, 2013,32(3):363-374
23. Jiao Y, Wang HC, Fan SJ. Growth suppression and radiosensitivity increase by HMGBI in breast cancer. Acta pharmacologica Sinica, 2007,28(12):1957-1967
24. Bernardini M, Lee CH, Beheshti B, et a1. High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer. Neoplasia, 2005,7(6):603-613
25. Barnes KR, Kutikov A, Lippard SJ. Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum (IV) complexes. Chem Biol, 2004,11(4):557-564
26. Gregory PA, Bracken CP, Smith E, et al. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell, 2011,22(10):1686-1698
27. Tobar N, Villar V, Santibanez JF. ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol Cell Biochem, 2010,340(1-2):195-202
28. Chua HL, Bhat-Nakshatri P, Clare SE. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene, 2007,26(5):711-724
29. Wu X, Mi Y, Yang H, et al. The activation of HMGB 1 as a progression factor on inflammation response in normal human bronchial epithelial cells through RAGE/JNK/NF-κB pathway, Mol Cell Biochem, 2013,380(1-2):249-257
30. Smolarczyk R, Cichoń T, Jarosz M, et al. HMGB1 - its role in tumor progression and anticancer therapy. Postepy Hig Med Dosw, 2012,22(66):913-920